Analyst Ratings for Phathom Pharmaceuticals (PHAT)

PHAT Rating Summary

PHAT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PHAT
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $56.67 (+70.3%) * Over Last 12-Mos
Rating Score: 8.6 / 10   Percentile Rank: 87%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/14/2021 Jones Trading Prakhar Agrawal New Coverage Buy
(N/A)
50.00
(N/A)
35.08
(33.27)
-5.16% Details
5/12/2021 Goldman Sachs Paul Choi Upgrade Neutral
(Sell)
48.00
(40.00)
32.97
(33.27)
0.91% Details
Like PHAT Ratings? Also take a look at TEVA, AMRX, RCKT, TRIL

PHAT Ratings News